Paper42897372PubMed
Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL.
Sağlam B and 7 others. Ann Hematol, 2026.
Cite this record
ConductScience Library. Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL. Papers, record 42897372. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42897372
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ferritin and LDH predict thrombotic risk beyond conventional scoring systems in DLBCL.
- Journal
- Ann Hematol
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-22
Source PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lymphoma, Large B-Cell, Diffuse | Major topic |
| L-Lactate Dehydrogenase | Major topic |
| Ferritins | Major topic |
| Thrombosis | Major topic |
| Humans | |
| Female | |
| Male | |
| Middle Aged | |
| Aged | |
| Retrospective Studies | |
| Adult | |
| Risk Factors | |
| Aged, 80 and over | |
| Predictive Value of Tests |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32528540 | The usefulness of lactate dehydrogenase measurements in current oncological practice. | Cell Mol Biol Lett | 2020 | https://conductscience.org/library/papers/32528540 | PubMed |
| 2 | 15925818 | Cancer and venous thromboembolism. | Lancet Oncol | 2005 | https://conductscience.org/library/papers/15925818 | PubMed |
| 3 | 17319909 | Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy. | J Thromb Haemost | 2007 | https://conductscience.org/library/papers/17319909 | PubMed |
| 4 | 35363373 | Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma. | Cancer | 2022 | https://conductscience.org/library/papers/35363373 | PubMed |
| 5 | 22710896 | Diffuse large B-cell lymphoma: current strategies and future directions. | Cancer Control | 2012 | https://conductscience.org/library/papers/22710896 | PubMed |
| 6 | 22364132 | Inflammation-induced thrombosis: mechanisms, disease associations and management. | Curr Pharm Des | 2012 | https://conductscience.org/library/papers/22364132 | PubMed |
| 7 | 20378755 | Thrombotic complications in adult patients with lymphoma: a meta-analysis of 29 independent cohorts including 18 018 patients and 1149 events. | Blood | 2010 | https://conductscience.org/library/papers/20378755 | PubMed |
| 8 | 16284987 | Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study. | Cancer | 2005 | https://conductscience.org/library/papers/16284987 | PubMed |
| 9 | 36207413 | The multiple roles of LDH in cancer. | Nat Rev Clin Oncol | 2022 | https://conductscience.org/library/papers/36207413 | PubMed |
| 10 | 23447056 | Gene expression levels of cytokines in peripheral blood mononuclear cells from patients with pulmonary embolism. | Mol Med Rep | 2013 | https://conductscience.org/library/papers/23447056 | PubMed |
| 11 | 39711462 | Incidence, Risk Factors, and Modified Risk Assessment Model of Venous Thromboembolism in Non-Hodgkin Lymphoma Patients. | Cancer Med | 2024 | https://conductscience.org/library/papers/39711462 | PubMed |
| 12 | 16258469 | Clotting mechanisms and cancer: implications in thrombus formation and tumor progression. | Clin Adv Hematol Oncol | 2003 | https://conductscience.org/library/papers/16258469 | PubMed |
| 13 | 30964109 | Clinical characteristics and prognosis of cancer patients with venous thromboembolism. | J Cancer Res Ther | 2019 | https://conductscience.org/library/papers/30964109 | PubMed |
| 14 | 15890969 | Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. | Arterioscler Thromb Vasc Biol | 2005 | https://conductscience.org/library/papers/15890969 | PubMed |
| 15 | 18216292 | Development and validation of a predictive model for chemotherapy-associated thrombosis. | Blood | 2008 | https://conductscience.org/library/papers/18216292 | PubMed |
| 16 | 16282243 | Risk factors for venous thromboembolic events in cancer patients. | Ann Oncol | 2006 | https://conductscience.org/library/papers/16282243 | PubMed |
| 17 | 35275231 | Higher ferritin levels in COVID-19 patients are associated with hyperinflammation, worse prognosis, and more bacterial infections without pronounced features of hemophagocytosis. | Ann Hematol | 2022 | https://conductscience.org/library/papers/35275231 | PubMed |
| 18 | 15302635 | Outcomes and cost of deep venous thrombosis among patients with cancer. | Arch Intern Med | 2004 | https://conductscience.org/library/papers/15302635 | PubMed |
| 19 | 12732602 | Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis. | Circulation | 2003 | https://conductscience.org/library/papers/12732602 | PubMed |
| 20 | 11549773 | Pathogenetic mechanisms of thrombosis in malignancy. | Acta Haematol | 2001 | https://conductscience.org/library/papers/11549773 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42897372
GET https://conductscience.org/api/papers/v1/42897372/references?page=2